No Data
Is Cardlytics, Inc. (CDLX) the Worst Marketing Stock to Buy?
Cardlytics, Inc. (CDLX): A Bull Case Theory
Favourable Signals For Cardlytics: Numerous Insiders Acquired Stock
Express News | Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Cardlytics, Inc. (CDLX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
Northland Securities Downgrades Cardlytics(CDLX.US) to Hold Rating, Cuts Target Price to $5
Northland Securities analyst Luke Horton downgrades $Cardlytics(CDLX.US)$ to a hold rating, and adjusts the target price from $7 to $5.According to TipRanks data, the analyst has a success rate of 50.